Cencora, Inc. (COR)

AmerisourceBergen Corporation is one of the largest global pharmaceutical sourcing and distribution services companies, serving healthcare providers and pharmaceutical/biotech manufacturers by improving patient access to products and enhancing patient care through an efficient pharmaceutical supply chain in both human and animal health. The company distributes brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter products, and home healthcare supplies to acute care hospitals, retail and mail order pharmacies, long-term care facilities, physician practices, veterinarians, and other providers across the United States and select global markets, while also offering value-added services such as data analytics, reimbursement consulting, logistics, inventory management, pharmacy automation, and packaging solutions. Operations are organized into two reportable segments: U.S. Healthcare Solutions, which includes pharmaceutical distribution, animal health (MWI Animal Health), consulting (Xcenda, Lash Group), and third-party logistics (ICS 3PL); and International Healthcare Solutions, comprising Alliance Healthcare, World Courier, Innomar, and Profarma, focused on pharmaceutical wholesale, specialty logistics, and commercialization services primarily in Europe and Canada.

The company's strategy centers on optimizing and growing both segments through operational efficiency, technology investment, and acquisitions—most notably the pending €1.28 billion acquisition of PharmaLex Holding GmbH, a life sciences services provider, expected to close by March 2023—as well as periodic divestitures of non-core businesses. Key industry growth drivers include an aging U.S. population, new pharmaceutical and biotech innovations, increased use of generics and biosimilars, expanded drug therapy utilization, and ongoing healthcare legislative developments, while the COVID-19 pandemic continues to present operational and financial uncertainties. The company's two largest customers, Walgreens Boots Alliance and Express Scripts, accounted for approximately 27% and 13% of fiscal 2022 revenue respectively, with its top 10 customers representing about 66% of total revenue; its ten largest suppliers accounted for approximately 46% of purchases.

AmerisourceBergen faces significant competition from McKesson Corporation, Cardinal Health, UPS Logistics, and other distributors, manufacturers, and specialty service providers. As of September 30, 2022, the company employed approximately 44,000 people, about 39,000 full-time, with roughly 39% based in the U.S. and 28% covered by collective bargaining agreements; it emphasizes diversity, equity, and inclusion initiatives, employee development, and comprehensive benefits programs. The company operates under extensive regulatory oversight from agencies including the DEA, FDA, and other U.S., U.K., and EU authorities, and must comply with laws such as the anti-kickback statute, False Claims Act, and the Drug Supply Chain Security Act, which governs traceability and licensing requirements for pharmaceutical wholesalers and logistics providers.